Biocon sees revenue growth of 14 per cent to Rs 1,784 crores in Q3FY20
EBITDA at Rs 480 crores, up 18 per cent
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biocon
Dr Kiran Mazumdar-Shaw honoured with Australia’s highest civilian honour
The award was given for her significant service to advancing Australia's bilateral relationship with India, particularly in…
True North to invest Rs 536.25 cr in Biocon Biologics for 2.44 per cent stake
Post the completion of this transaction, Biocon will hold 96.07 per cent stake in Biocon Biologics
Biocon and Equillium expand exclusive licensing agreement for Itolizumab to include Australia and…
Equillium had originally secured exclusive rights to develop and commercialize Biocon’s novel biologic, itolizumab, for the US and…
Biocon appoints Siddharth Mittal as its CEO and Joint MD
He takes over from Dr Arun Chandavarkar who retired as Chief Executive Officer & Joint Managing Director of Biocon on November…
USFDA approves Biocon’s sBLA for Pegfilgrastim new manufacturing facility
Expanded capacity will enable greater patient access globally
ICMR honours Kiran Mazumdar-Shaw with Lifetime Achievement Award
Shaw was recognised for her philanthropic efforts, and providing better healthcare to people in India and globally through…
Biocon features in the ASIA IP ELITE list for the fourth consecutive year
Biocon Biologics debuts on the ASIA IP ELITE 2019 list
Biocon moves up to rank no 6 on Science Careers’ top 20 global pharma and biotech employers list…
Ranked at number six among global pharma and biotech companies in 2019, Biocon has moved up from number seven in 2018 and number…
Biocon announces Q2FY20 Earnings
Net profit on a yoy basis was lower at Rs 216 crore (vs. Rs 355 corer in Q2FY19) due to an exceptional income of Rs 171 crore…